Engineered exosomes, designed to express the hepatocellular carcinoma antigen α-fetoprotein, have unveiled a potent anti-tumor response by dampening immunosuppressive cytokines and amplifying the presence of IFN-γ-expressing CD8+ T cells (36). The gene discussed is IFNG; the disease is neoplasm.